Effexor withdrawal. Effexor withdrawal steps detailed. Effexor withdrawal
outlined. Effexor withdrawal. How to safely do Effexor withdrawal.
Effexor withdrawal.
Effexor Withdrawal Solution, Venlafaxene Side Effects, Treatment Options
Effexor Withdrawal Symptoms
The majority of people attempting Effexor withdrawal experience an
antidepressant withdrawal syndrome. This is also known as Effexor
discontinuation syndrome in the United States. In Europe it is call Effexor
withdrawal side effects. The F.D.A. estimates 10% of those experiencing Effexor
withdrawal will go back up on the Effexor because the withdrawal symptoms are
too severe.
If you want to read the short version of how to handle Effexor withdrawal side effects
Click here. Page opens new browser window.
The most common and debilitating Effexor withdrawal side effect is called "brain
zaps." Brain zaps are described by people experiencing it as a; electrical jolt that
tends to run from base of the neck up into their head. Another side effect that tends
to run with brain zaps is a shiver, a feeling as your head is floating, dizziness,
and/or a whirling sensation in the head.
These symptoms can come in waves or even be persistent.
The good news; in 2002, our founder, Jim Harper, discovered the correct type of
Omega 3 taken in the right quantity will eliminate these devastating head
symptoms quickly. Usually within a couple of hours.
The body in a normal state uses the oil from our diet, specifically from omega 3
found in fish, to build and replenish the end point of areas in the brain that sends
and receives electrical signals. We are using easy to understand terminology here
so it is easy to understand. Let's leave the technical jargon to physicians.
These brain zaps have nothing to do with serotonin levels or other made up
reasons. It is simple really; our body works in a very natural way with how it uses
amino acids, proteins, fats in food and all other diet items to maintain a balance.
When you introduce any toxin that disrupts these processes the body reacts.
The most common Effexor Venlafaxene withdrawal symptoms reported include:
Flu like symptoms
Insomnia
Anxiety
Brain zaps
Tremors
Diarrhea
Vomiting
Increased suicidal ideation
Nausea
Headache
Mania
Hypomania
Ringing in the ears
Aggression
Confusion
Imbalance
Mood swings
Please note: These are the most common Effexor withdrawal side effects but far
from all potential Effexor withdrawal side effects.
There is a warning the FDA has put a black box warning on Effexor.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORSSee full
prescribing information for complete boxed warning. Antidepressants
increased the risk of suicidal thoughts and behaviorsin pediatric and young
adult patients (5.1) Closely monitor for clinical worsening and emergence of
suicidalthoughts and behaviors
You may have been prescribed Effexor within a very short doctor visit. There was
no investigation into other life factors, lab testing, or any conversation about what
side effects might present. The failings of this approach may cause quite a burden
on the patient.
Depression, insomnia, anxiety, fibromyalgia, and other symptoms that Effexor is
often prescribed for might stem from; diminished vitamin D levels, over active
JNK gene, specific proteins that need to be silenced, dietary concerns and food
allergies, mitochondrial dysfunction, neurotoxic accumulation, and many other
reasons. A full physical from an understanding physician is ideal, before
prescribing Effexor.
Do Your Symptoms Require Effexor?
The Road Back Program uses nutritional supplements to help with the Effexor
withdrawal. Most people feel a very fast relief from the Effexor withdrawal once
they begin taking the supplements and we feel the odds are high; if would have
taken nutritional supplements like these before starting the Effexor you would have
been prescribed the Effexor in the first place.
In 2007, Jim Harper was giving a speech to a group of psychiatrists in Ireland and
during his talk he mentioned his mother just passed away 30 days ago. He went on
to describe how he made sure to take his JNK Formula each day to help the body
cope with the stress being put on it do to his loss. He went on to say, "The JNK
Formula will not remove the emotional loss and how I feel but it will keep the
body strong during my time to grieve."
How Do You Survive Effexor Withdrawal?
Surviving Effexor withdrawal depends on what you do at this very moment. If you
keep doing the same thing you have been doing and you are in a heavy Effexor
withdrawal, nothing will change for the positive, That is a given.
If you decide to do the Effexor withdrawal as an inpatient in a drug rehab center
DO NOT DO THE 9 DAY PLAN BECAUSE THAT WHAT INSURANCE
ALLOWS. Over the past 22 years I have worked with far to many people who
were sold on a rehab facility, stayed the 9 days because insurance would only pay
for that amount of time. The unscrupulous facility took them off the Effexor in 9
days as they promised and by the time the person got off the airplane after their
return home they were in full withdrawal. You can't do a Effexor withdrawal in 9
days.
The Road Back Program can normally help you get back on your feet again
but the rehab facility approach of this type is not worth the price you will pay
mentally and physically.
You will find a few other outpatient Effexor withdrawal programs on the internet
now and Jim Harper is not aware of one that will cause you harm like the rehab
facility's mentioned. However, every other program on the internet was trained by
Jim Harper years ago and they are doing what Jim Harper and The Road Back did
during that time frame. Almost 2 decades ago Jim Harper trained several
physicians and good intentioned people how to get a patient off Effexor. Jim went
in to detail of the process and what nutritional supplements were used and why
they were used. At that time of The Road Back the success rate was not as high as
desired and over the following years Jim changed the formulas used with the
supplements several times to use new information with DNA testing. Long story
short; you will likely wind up using a Effexor withdrawal approach The Road Back
used in 2003, that was scrapped for something more successful.
If you are currently in Effexor withdrawal, send Jim Harper an email and he will
personally guide you through the process so you can get back on your feet quickly
and have a very successful Effexor withdrawal.
It does not matter if you have been on Effexor for 1 month or 20 years. Recovery
can happen and the good part is; it does not take more time because you have been
taking Effexor for years.
When Do Effexor Withdrawal Symptoms Start When
Discontinuing / Quitting Effexor?
Effexor withdrawal usually begins between day 1 and day 3 of adjusting the
Effexor. For some people this is not the case but eventually most everyone hits
some dosage of the Effexor when reducing that jars them. Effexor withdrawal
begins and they have no idea what they should do. Their physician does not know
what to do. They wind up in a spiral downward and wind up on a new medication
to try and stop the Effexor withdrawal. The best case is the additional drug does
that but you are now on 2 drugs instead of only Effexor.
What is Effexor?
Effexor is an antidepressant medication developed in the 1970s
with FDA approval
granted in 1991. This SSRI drug is prescribed in treating adult depressive disorders
(MDD), panic disorder, obsessive compulsory disorders (OCD), social anxiety
(SAD), post-traumatic stress disorders (PTSD), and premenstrual dysphoric
disorder (PMDD).
If you have anxiety before taking Effexor, or anxiety begins while taking Effexor,
odds are the anxiety will continue to get worse. Effexor alters dopamine much like
the antidepressant Effexor and anxiety is a byproduct of these two drugs.
What Is Effexor Used For?
Effexor is an antidepressant medication approved to treat adult MDD (major
depressive disorder). The Black Box warning on the drug’s packaging mentions
that the drug should not be prescribed to anyone under the age of 25, due to
heightened risk of suicide. There is an exception to this for patients under the age
of 25 who have been diagnosed with OCD (obsessive-compulsive disorder).
Potential suicidality is associated with all Effexor and may be a concern leading to
consider Effexor withdrawal, which is recommended to be done always under
medical or caregiver monitoring.
Adult-only approved uses for the drug provided in a clinical or treatment
setting include:
MDD: Major Depressive Disorder<
PTSD: Post-traumatic stress disorder
PD: Panic disorder
SAD: Social anxiety disorder
OCD: Obsessive-compulsive disorder
PMDD: Premenstrual dysphoric disorder
Effexor Side Effects
The full list of Effexor side effects is quite staggering. In 2004, Jim Harper used
the Freedom of Information Act to get the full list of Effexor side effects. Jim
received the information and it is 500 sheets of letter size paper, single space, a
number 10 font size, 3 columns per page. In other words, thousands of known
potential Effexor side effects were disclosed.
Some of the other Effexor and Effexor withdrawal side effects:
Serotonin syndrome: A life-threatening condition requiring immediate
medical care in a hospital emergency clinic or ICU. Symptoms to watch
for include sudden fever, losing consciousness, inability to move or
speak, copious sweating, dilated pupils, chills, tremors, convulsions,
diarrhea, agitation, restlessness, racing heart, etc.
Suicidal thoughts (common)
Suicide attempt (common)
Hyperkinesis (muscle spasms, movement disorder)
Worsened depression
Aggression
Paranoia (rare)
Anxiety
Mania (common)
Convulsions
Unconsciousness
Coma
Teeth grinding
Akathisia (relentless internal restlessness and discomfort marked by
repeated motions, pacing, rocking, etc., that can lead to suicidal
thoughts as a means of relief)
Tachycardia (racing heart, even when the body is at rest)
Rash
Itching
Burning, crawling feeling in the skin
Fever
Tics, sudden jerky movements, myoclonus
Emotional blunting
Behavioral apathy, SSRI-induced-indifference
Pain on urination or difficulty urinating
Cloudy urine
Headache
Sexual impairments, i.e., anorgasmia, inability to ejaculate, lowered
libido
Mood swings
Pain around the eyes or eye sockets
Sleepiness
Bladder pain
Prickling skin sensation
Numbness
Sensory disturbances
Insomnia
Depersonalization (common)
Nervousness
Nightmares (paroniria)
Hostility
Nausea
Diarrhea
Weight gain
Some documented Effexor birth defects and injuries include:
PPHN or persistent pulmonary hypertension of the newborn, a heart and
lung condition which can result in respiratory failure, decreased oxygen to
the brain, and multiple organ injuries.
Congenital Heart Defects connected to Effexor and other SSRIs include
ventricular septal defects and atrial septal defects, also referred to as “holes
in the heart”, related to heart murmurs, suppressed appetite, breathing
difficulties, tiredness, inadequate growth, etc.
Increased Risk of Autism has been extensively reported but evidence has
not yet been considered conclusive enough for regulatory bodies to ban
prescribing to pregnant women.
Increased Risk of Clubfoot connected to SSRIs during pregnancy as
reported by NIMH, where exposure had the highest increase in clubfoot of
all SSRIs.
Increased risk of atrial/ventricular defects and craniosynostosis was
reported in a Canadian study from 1998 to 2010 and published in the June
2015 issue of the American Journal of Gynecology & Obstetrics.
Effexor Withdrawal, What to Expect
If using The Road Back Program you should expect to feel a lot better within the
first couple days of the program. If you do nothing, expect to continue to feel as
you do now. Possibly worse as time goes on. The chance of feeling better if you do
nothing is nil.
In 1999, The Road Back only had people taper the Effexor gradually and slowly.
They still suffered. Around 50% could get off the Effexor but most went back on
the Effexor because they continual Effexor withdrawal side effects would not
diminish or go away.
We wish there was a better answer for you than the above but with working with
over 19 million people over the last 22 years, the truth is the truth. No way to water
it down to make it sound better.
Some may think it is just their depression returning but who would not feel
depressed if they were still going through Effexor withdrawal months after
stopping the Effexor.
We can't stress enough; what you do or do not do at this moment in time is critical
for your future. Take your time if at all possible. If you have brain zaps go buy any
omega 3 fish oil, even the wrong omega 3 fish oil will help somewhat.
While you read this you may want to pause and go take a walk. Look at the trees,
the sky or anything off in the distance. Getting your attention off your mind and
body may do wonders.
Keep this close to your heart; There is Hope and There is a Solution. We are
speaking directly to YOU.
A 30 day supply of the nutritional supplements will cost you around $80. If you
feel it is worth $80 to take a chance that all of this can go away in a couple of days,
then take that chance. Over the past 22 years many have sent an email to Jim
Harper and said they were not sure what to do about the Effexor withdrawal. Even
after reading this information. The people that tried something else generally came
back within a few months and were in worse shape than before. We do not want
this to happen to you. But if is; Jim will still be here to assist.
Can Effexor Make Depression Worse?
Common sense answers this question. If depression is one side effect of taking
Effexor then Effexor can cause depression. You do stand a greater chance of
Effexor causing depression during withdrawal than while simply taking the
Effexor as prescribed. The depression during Effexor withdrawal can be due to the
other Effexor withdrawal side effects you are experiencing. Who would not start to
get depressed if you have anxiety from morning to night, can't sleep and your head
feels like it is on fire.
Effexor Aggression in Children
Children are more prone to aggression when taking Effexor than adults. It occurs
in 10-20% of children taking any SSRI antidepressant. Two clinical trials
performed by Pfizer, aggression was the most common reason noted for Effexor
discontinuation.
Can You Get Addicted to Effexor?
Yes and no. This is where Effexor dependence is a matter of wording. Medically
speaking in the United States Effexor is not addicting. In Europe it is viewed as
addicting. The bottom line is; Once you take Effexor for 7 days the Effexor has
made its way through your body. If your body no longer has the Effexor in its
system, your body will react to the Effexor being gone.
Much like a person that eats a lot a sweets every day. Your body will react when
the sweet substance is not present. Call it addicting, as we would, call it a
dependence as United States physicians will, it is what it is. If you do not provide
the substance the body reacts and you also have mental feelings that are not
positive. We can get into the insulin discussion etc, but we are only talking about a
substance being present and then not and the body and mind reacting in a negative
manner.
What is the difference between Effexor and a Benzodiazepine?
Effexor is an SSRI medication, an antidepressant, used to treat depression and
anxiety. Benzodiazepines are prescribed mainly for the treatment of anxiety and
panic disorders but also prescribed off-label to treat depression.
These two types drug have different chemical components and were designed to
work on different brain receptors and neurotransmitters, but some of their effects
can be seen to overlap. Benzodiazepines are thought to mainly affect GABA
transmission, which can slow the central nervous system to reduce anxiety, while
Effexor is designed to block the reuptake of serotonin.
Benzodiazepines are known to be more prone to dependence/addiction than
Effexor. While the withdrawal symptoms are similar between both drugs,
Effexor’s half-life is 22-36 hours, and Benzodiazepines half-life is much lower.
Benzodiazepines can have more severe complications if abruptly stopped,
including seizures. For safe Benzodiazepine or Effexor withdrawal, either of these
drugs must be slowly tapered to allow the central nervous system and
neurochemistry to safely normalize.
Choosing to withdrawal from the Effexor first or the benzodiazepine first needs to
be evaluated. Use Chapter 23, The Science to decide is part of that equation.
Depending on the benzodiazepine you may be taking with the Effexor, if you
reduce the Effexor first it may make you go into withdrawal on the
benzodiazepine, even if you did not reduce the benzodiazepine.
How long does Effexor stay in your system after the last dosage?
Our founder, Jim Harper, made great strides with determining this question. Using
his DNA testing company in 2004-2005, Jim conducted hundreds of DNA tests to
determine how fast or slow medications took to metabolize. In roughly 34 percent
of the population the Effexor can take as long as 48 hours to clear the body. In
others, as little as 8 hours can occur for the Effexor to clear the body.
Depending on other habits you may have, Effexor could clear faster or even take
more time than the 48 hours. If you smoke cigarettes and stop smoking while
taking Effexor, the Effexor dosage you are taking will decrease by 15%. On the
other side of this, if you start smoking while taking Effexor, the Effexor dosage
will act as though it is 15% higher than you think it is. This is because cigarettes
induce an enzyme used to metabolize Effexor and anything using that same
pathway will shoot though much faster. Caffeine restricts that same enzyme, so if
you start or stop drinking coffee while taking Effexor you will either go into
withdrawal or feel an overdose, even though you have not changed the Effexor
dosage.
This is why The Road Back Program wants you to not change smoking habits or
caffeine habits during the Effexor taper.
Can you overdose on Effexor?
Yes, it is definitely possible for Effexor poisoning to occur. A substantial Effexor
overdose requires emergency medical intervention to prevent major health
problems. This list of Effexor overdose symptoms would be the same as those
Effexor side effects listed above, but more severe.
According to the National Institute of Health (NIH), the use of intravenous
benzodiazepines is sometimes required during Effexor overdose to prevent
seizures. Extra cooling measures must be used to reduce hyperthermia, always
under the direction of EMT or other medical staff attending to the patient.
Treatment for Effexor Withdrawal
Effexor has become one of the most frequently prescribed antidepressants in the
US. Of equal importance is that depressive disorders have become one of the most
frequently diagnosed conditions. These two facts together underscore two
important steps toward improved health:
Providing safe treatment programs for those who have decided on Effexor
withdrawal, and
Offering drug-free options to regain natural mental health without the need
for prescription medications.
The Road Back Program was described by Dr. Hyla Cass M.D. in this way:
Here's an essential handbook on how to safely and more easily wean yourself
(under medical supervision) off the heavily over-prescribed psychotropic
medications. I have used the program with my patients and it works!" Hyla
Cass M.D. Author of Supplement Your Prescription
Send an email to Jim Harper by using the Contact link on the top of this page or
read How to Get Off Psychoactive Drugs Safely by Jim Harper and follow the
program for Effexor withdrawal. Why Jim put his entire book on our website
for free is so you can instantly read the material and start this process if you are
ready now.
One last thing Jim asked us to provide at the bottom of each page of Effexor
descriptions:
There is Hope and There is a Solution
REFERENCES
Bailey, L.B., Gregory, J.F., (1999). “Polymorphisms of methylenetetrahydrofolate
reductase and other enzymes: metabolic significance, risks and impact on folate
requirement.” J Nutr 129(5): 919-22.
Bailey, L.B., Gregory, J.F., (1999). “Folate metabolism and requirements.” J Nutr
129(4): 779-82.
Basile, V.S., Masellis, M., Potkin, S.G., Kennedy, J.L., Pharmacogenomics in
schizophrenia: the quest for individualized therapy. Hum Mol Genet. 2002 Oct
1;11(20):2517-30
Blaisdell, J., Mohrenweiser, H., Jackson, Ferguson, J., Coulter, S., Chanas, S.,
Chanas, B., Xi, T., Ghanayem, B., Goldstein, J.A. Identification and functional
characterization of new potentially defective alleles of human CYP2C19.
Pharmacogenetics. 2002 Dec;12(9):703-11.
Bosron, W.F., Ting-Kai, L., (1986). “Genetic polymorphism of human liver
alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism
and alcoholism.” Hepatology 6(3): 502 – 510.
Bradford, L.D., CYP2D6 allele frequency in European Caucasians, Asians,
Africans and their descendants. Pharmacogenomics. 2002 Mar;3 (2):229-43.
Brockmoller, J., et.al. Pharmacogenetic diagnosis of cytochrome P450
polymorphisms in clinical drug development and in drug treatment.
Pharmacogenetics. 2000:1:125-51.
Budziszewska B, Szymanska M, Leskiewicz M, Basta-Kaim A, Jaworska-Feil L,
Kubera M, Jantas D, Lason W. The decrease in JNK- and p38-MAP kinase activity
is accompanied by the enhancement of PP2A phosphate level in the brain of
prenatally stressed rats. J Physiol Pharmacol. 2010 Apr;61(2):207-15.
Carter CJ. Multiple genes and factors associated with bipolar disorder converge on
growth factor and stress activated kinase pathways controlling translation
initiation: implications for oligodendrocyte viability. Neurochem Int. 2007
Feb;50(3):461-90. Epub 2007 Jan 18. Review.
Ceriello, A., Giugliano, D., Quatraro, A., Lefebvre, P.J., Anti-oxidants show an
anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci
1991;81:739-42.
Chang, T.K., et al. Enhanced cyclophosphamide and ifosfamide activation in
primary human hepatocyte cultures: response to cytochrome P-450 inducers and
autoinduction by oxazaphosphorines. Cancer Res 1997; 57(10):1946-54.
Chango, A., Boisson, F., et al. (2000). “The effect of 677C-->T and 1298A-->C
mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase
activity in healthy subjects.” Br J Nutr 83(6): 593-6.
Charradi K, Sebai H, Elkahoui S, Ben Hassine F, Limam F, Aouani E. Grape Seed
Extract Alleviates High-Fat Diet-Induced Obesity and Heart Dysfunction by
Preventing Cardiac Siderosis. Cardiovasc Toxicol. 2011 Jan 14.
Cheng, T., Zhu, Z., et al. (2001). “Effects of multinutrient supplementation on
antioxidant defense systems in healthy human beings.” J Nutr Biochem 12(7): 388-
395.
Chida, M., Yokoi, T., Fukui, T., Kinoshita, M., Yokota, J., Kamataki, T., Detection
of three genetic polymorphisms in the 5’-flanking region and intron 1 of human
CYP1A2 in the Japanese population. Jpn J Cancer Res. 1999 Sep;90(9):899-902
Chistyakov, D. A., Savost’anov, et al. (2001). “Polymorphisms in the Mn-SOD
and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes
mellitus.” BMC Med Genet 2(1): 4.
Cosma, G., Crofts, F., et al. (1993). “Relationship between genotype and function
of the human CYP1A1 gene.” J Toxicol Environ Health 40(2-3): 309-16.
Cozza, K.L., Armstrong, S.C., Oesterheld, J.R., Drug Interaction principles for
Medical Practice. American Psychiatric Publishing Inc. (2003)
Chuang DM. Neuroprotective and neurotrophic actions of the mood stabilizer
lithium: can it be used to treat neurodegenerative diseases? Crit Rev Neurobiol.
2004;16(1-2):83-90. Review.
Das J et al. Acetaminophen induced acute liver failure via oxidative stress and JNK
activation: protective role of taurine by the suppression of cytochrome P450 2E1.
Free Radic Res. 2010; 44(3): 340-55.
Gao N, Budhraja A, Cheng S, Yao H, Zhang Z, Shi X. Induction of apoptosis in
human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-
terminal kinase.
Clin Cancer Res. 2009 Jan 1;15(1):140-9.
Ho, P.C., et al. Influence of CYP2C9 genotypes on the formation of a hepatotoxic
metabolite of valproic acid in human liver microsomes. Pharmacogenomics J 2003;
3(6):335-42.
Jeong SW, Kim LS, Hur D, Bae WY, Kim JR, Lee JH. Gentamicin-induced spiral
ganglion cell death: apoptosis mediated by ROS and the JNK signaling pathway.
Acta Otolaryngol. 2010 Jun;130(6):670-8.
Lam, Y.W.F., Gaedigk, A., Ereshefsy, L., et al: CYP2D6 inhibition by selective
serotonin reuptake inhibitors: analysis of achievable steady-state plasma
concentrations and the effect of ultrarapid metabolism at CYP2D6.
Pharmacotherapy 2002;22:1001-1006.
Lichtenstein AH, Appel LJ, Brands M et al. Diet and lifestyle recommendations
revision 2006: a scientific statement from the American Heart Association
Nutrition Committee. Circulation, 2006; 114: 82-96.
Lin CL, Lin JK. Epigallocatechin gallate (EGCG) attenuates high glucose-induced
insulin signaling blockade in human hepG2 hepatoma cells. Mol Nutr Food Res.
2008; 52(8): 930-9.
Liu H, Xiao Y, Xiong C, Wei A, Ruan J. Apoptosis induced by a new flavonoid in
human hepatoma HepG2 cells involves reactive oxygen species-mediated
mitochondrial dysfunction and MAPK activation. Eur J Pharmacol. 2011 Jan 15.
Madhyastha R, Madhyastha H, Nakajima Y, Omura S, Maruyama M. Curcumin
Facilitates Fibrinolysis and Cellular Migration during Wound Healing by
Modulating Urokinase Plasminogen Activator Expression. Pathophysiol Haemost
Thromb. 2010 Nov 12
Maheshwari A, Misro MM, Aggarwal A, Sharma RK, Nandan D. N-Acetyl-L-
cysteine counteracts oxidative stress and prevents H(2) O(2) induced germ cell
apoptosis through down-regulation of caspase-9 and JNK/c-Jun. Mol Reprod Dev.
2010 Dec 22. doi: 10.1002/mrd.21268.
Moon et al. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation
of 3T3-L1 cells. Obesity (Silver Spring). 2007; 15(11): 2571-82.
Pan J, Xiao Q, Sheng CY, Hong Z, Yang HQ, Wang G, Ding JQ, Chen SD.
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3)
attenuates dopaminergic neuronal damage in mouse model of Parkinson’s disease.
Neurochem Int. 2009 Jun;54(7):418-25. Epub 2009 Jan 29.
Ramerstorfer J, Furtmüller R, Sarto-Jackson I, Varagic Z, Sieghart W, Ernst M.
The GABAA Receptor malpha?+ebetaS- Interface: A Novel Target for Subtype
Selective Drugs. J Neurosci. 2011 Jan 19;31(3):870-7
Romier-Crouzet B, Van De Walle J, During A, Joly A, Rousseau C, Henry O,
Larondelle Y, Schneider YJ. Inhibition of inflammatory mediators by polyphenolic
plant extracts in human intestinal Caco-2 cells. Food Chem Toxicol. 2009
Jun;47(6):1221-30. Epub 2009 Feb 20.
Spiliotaki M, Salpeas V, Malitas P, Alevizos V, Moutsatsou P. Altered
glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder
patients. Psychoneuroendocrinology. 2006 Jul;31(6):748-60. Epub 2006 Apr 18.
Stornetta RL, Zhu JJ. Ras and Rap Signaling in Synaptic Plasticity and Mental
Disorders. Neuroscientist. 2010 Apr 29.
Tian H, Zhang G, Li H, Zhang Q. Antio
xidant NAC and AMPA/KA receptor
antagonist DNQX inhibited JNK3 activation following global ischemia in rat
hippocampus. Neurosci Res. 2003 Jun;46(2):191-7.
Waltner-Low ME et al. Epigallocatechin gallate, a constituent of green tea,
represses hepatic glucose production. J Biol Chem. 2002; 277(38): 34933-40.
Wu H et al. JNK-dependent NFATc1 pathway positively regulates IL-13 gene
expression induced by (-)-epigallocatechin-3-gallate in human basophilic KU812
cells. Free Radic Biol Med. 2009; 47(7): 1028-38.
Wu N et al. Taurine prevents free fatty acid-induced hepatic insulin resistance in
association with inhiditing JNK1 activation and improving insulin signaling in
vitro. Diabetes Res Clin Pract. 2010; 90(3): 288-90.
Xie N, Wang C, Lin Y, Li H, Chen L, Zhang T, Sun Y, Zhang Y, Yin D, Chi Z.
The role of p38 MAPK in valproic acid induced microglia apoptosis. Neurosci
Lett. 2010 Sep 20;482(1):51-6. Epub 2010 Jul 16.
Xu Y, Hou XY, Liu Y, Zong YY. Different protection of K252a and N-acetyl-L-
cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving
inhibition of MLK3-MKK7-JNK3 signal cascades. J Neurosci Res. 2009
Mar;87(4):918-27.
Yaniv SP, Lucki A, Klein E, Ben-Shachar D. Dexamethasone enhances the
norepinephrine-induced ERK/MAPK intracellular pathway possibly via
dysregulation of the alpha2-adrenergic receptor: implications for antidepressant
drug mechanism of action. Eur J Cell Biol. 2010 Sep;89(9):712-22.
Zhang F, Lau SS, Monks TJ. The Cytoprotective Effect of N-acetyl-L-cysteine
against ROS-induced Cytotoxicity is Independent of its Ability to Enhance
Glutathione Synthesis. Toxicol Sci. 2010 Dec 6.